|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,889.20 INR | +0.11% |
|
-0.38% | -8.94% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 24.21B | 31.49B | 38.02B | 39.62B | 40.91B | |||||
Other Revenues, Total | - | - | - | - | 3M | |||||
Total Revenues | 24.21B | 31.49B | 38.02B | 39.62B | 40.92B | |||||
Cost of Goods Sold, Total | 13.48B | 19.05B | 23.26B | 22.62B | 23.6B | |||||
Gross Profit | 10.74B | 12.43B | 14.76B | 16.99B | 17.32B | |||||
Selling General & Admin Expenses, Total | 3.08B | 3.21B | 3.95B | 4.5B | 4.56B | |||||
Depreciation & Amortization - (IS) | 755M | 759M | 825M | 823M | 894M | |||||
Other Operating Expenses | 4.15B | 4.84B | 5.53B | 6.15B | 6.33B | |||||
Other Operating Expenses, Total | 7.98B | 8.82B | 10.31B | 11.48B | 11.78B | |||||
Operating Income | 2.76B | 3.62B | 4.45B | 5.51B | 5.53B | |||||
Interest Expense, Total | -100M | -90M | -99M | -97M | -91M | |||||
Interest And Investment Income | 199M | 194M | 255M | 356M | 262M | |||||
Net Interest Expenses | 99M | 104M | 156M | 259M | 171M | |||||
Currency Exchange Gains (Loss) | -67M | -31M | -17M | -5M | - | |||||
Other Non Operating Income (Expenses) | 13M | -38M | -31M | -28M | -7M | |||||
EBT, Excl. Unusual Items | 2.8B | 3.65B | 4.56B | 5.74B | 5.7B | |||||
Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | 7M | - | - | 11M | |||||
Gain (Loss) On Sale Of Assets | -26M | -20M | -11M | -11M | -7M | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | 8M | 29M | 8M | 2M | - | |||||
EBT, Incl. Unusual Items | 2.78B | 3.67B | 4.56B | 5.73B | 5.7B | |||||
Income Tax Expense | 706M | 767M | 1.21B | 1.46B | 1.4B | |||||
Earnings From Continuing Operations | 2.08B | 2.9B | 3.35B | 4.27B | 4.3B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 2.08B | 2.9B | 3.35B | 4.27B | 4.3B | |||||
Net Income - (IS) | 2.08B | 2.9B | 3.35B | 4.27B | 4.3B | |||||
Net Income to Common Incl Extra Items | 2.08B | 2.9B | 3.35B | 4.27B | 4.3B | |||||
Net Income to Common Excl. Extra Items | 2.08B | 2.9B | 3.35B | 4.27B | 4.3B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 45.59 | 63.7 | 73.58 | 93.68 | 94.31 | |||||
Basic EPS - Continuing Operations | 45.59 | 63.7 | 73.58 | 93.68 | 94.31 | |||||
Basic Weighted Average Shares Outstanding | 45.54M | 45.54M | 45.54M | 45.54M | 45.54M | |||||
Net EPS - Diluted | 45.59 | 63.7 | 73.58 | 93.68 | 94.31 | |||||
Diluted EPS - Continuing Operations | 45.59 | 63.7 | 73.58 | 93.68 | 94.31 | |||||
Diluted Weighted Average Shares Outstanding | 45.54M | 45.54M | 45.54M | 45.54M | 45.54M | |||||
Normalized Basic EPS | 38.43 | 50.12 | 62.61 | 78.76 | 78.16 | |||||
Normalized Diluted EPS | 38.43 | 50.12 | 62.61 | 78.76 | 78.16 | |||||
Dividend Per Share | 50 | 75 | 65 | 75 | 100 | |||||
Payout Ratio | 74.57 | 109.89 | 81.53 | 96.09 | 100.72 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.34B | 4.19B | 5.09B | 6.15B | 6.24B | |||||
EBITA | 2.77B | 3.63B | 4.46B | 5.52B | 5.54B | |||||
EBIT | 2.76B | 3.62B | 4.45B | 5.51B | 5.53B | |||||
EBITDAR | 3.36B | 4.21B | 5.11B | 6.18B | 6.27B | |||||
Total Revenues (As Reported) | 24.45B | 31.71B | 38.3B | 39.97B | 41.19B | |||||
Effective Tax Rate - (Ratio) | 25.38 | 20.91 | 26.5 | 25.55 | 24.64 | |||||
Total Current Taxes | 763M | 782M | 1.26B | 1.51B | 1.41B | |||||
Total Deferred Taxes | -57M | -15M | -53M | -44M | -5M | |||||
Normalized Net Income | 1.75B | 2.28B | 2.85B | 3.59B | 3.56B | |||||
Interest on Long-Term Debt | 67M | 73M | 76M | 71M | 74M | |||||
Non-Cash Pension Expense | 7M | 9M | 17M | 23M | 33M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 537M | 549M | 916M | 1.19B | 1.15B | |||||
Selling and Marketing Expenses | 537M | 549M | 916M | 1.19B | 1.15B | |||||
Research And Development Expense From Footnotes | 123M | 130M | 101M | 114M | 135M | |||||
Net Rental Expense, Total | 25M | 23M | 26M | 28M | 37M | |||||
Imputed Operating Lease Interest Expense | 31.2M | 24.64M | 29.38M | 33.4M | 43.98M | |||||
Imputed Operating Lease Depreciation | -6.2M | -1.64M | -3.38M | -5.4M | -6.98M | |||||
Maintenance & Repair Expenses, Total | 251M | 270M | 358M | 397M | 419M | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | 31M | 28M | |||||
Total Stock-Based Compensation | - | - | - | 31M | 28M |
- Stock Market
- Equities
- AKZOINDIA Stock
- Financials Akzo Nobel India Limited
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















